Context Therapeutics CNTX
NASDAQ CNTX
$0.23 -0.01 (-5.09%)
At close: Oct 21, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Share-based Compensation (2020 - 2026)

Updated

Context Therapeutics' Share-based Compensation came in at $528,102 for Q2 2026, up 35.7% from $389,114 a year earlier and up 29.1% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Context Therapeutics reported Share-based Compensation of $1.59 million, up 40.6% year-over-year; for FY2025, it was $1.33 million, up 58.1% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $841,867 in FY2024 (-21.8%), $1.08 million in FY2023 (+10.3%), $976,440 in FY2022 (+91.1%) and $511,079 in FY2021 (+133.1%).
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q4 2020.
  • Year-over-year, Share-based Compensation has increased for six consecutive quarters, with growth averaging 38.9% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q1 2022 (growth of 742.5%), and the weakest in Q2 2024 (a decline of 44.5%).
  • Business Quant data shows CNTX's Share-based Compensation at $409,220 (Q1 2026), $325,168 (Q4 2025) and $323,081 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 Context Therapeutics 21.74 Mn -218.72 Mn - 528,102.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 528,102.00
Mar 31, 2026 409,220.00
Dec 31, 2025 325,168.00
Sep 30, 2025 323,081.00
Jun 30, 2025 389,114.00
Mar 31, 2025 293,717.00
Dec 31, 2024 231,821.00
Sep 30, 2024 213,002.00
Jun 30, 2024 157,037.00
Mar 31, 2024 240,007.00
Dec 31, 2023 256,051.00
Sep 30, 2023 254,949.00
Jun 30, 2023 283,103.00
Mar 31, 2023 282,762.00
Dec 31, 2022 243,637.00
Sep 30, 2022 276,521.00
Jun 30, 2022 241,324.00
Mar 31, 2022 214,958.00
Dec 31, 2021 204,380.00
Sep 30, 2021 161,823.00
API Access

Context Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CNTX&period=max&api_key=YOUR_API_KEY